For citations:
Serikova S.N., Korochanskaya N.V., Usova O.A., Barcho R.A., Pryadko E.I., Georgiadu V.A. Ustekinumab as first line therapeutic choice of biological therapy in bionaive patient affected with ulcerative colitis and intestinal reactivation of cytomegalovirus infection. Medical alphabet. 2023;(34):6-10. (In Russ.) https://doi.org/10.33667/2078-5631-2023-34-6-10
Email this article 